NSC |
Compound |
Enrichment |
Correlation |
NSC 643915 |
Naphtho[2,3-d]oxazole-4,9-dione, 2-(1,1-dimethylethyl)- |
0.0490935610249072 |
0.2991147 |
NSC 658387 |
6,9-Ethanobenzo[g]quinoxaline-5,10-diol, 6,9-dihydro- 2,3-dimethyl- |
0.0490935610249072 |
0.4906779 |
NSC 665883 |
Null |
0.0490935610249072 |
-0.065554668 |
NSC 683247 |
Acridine-4-carboxamide, 9-amino-5-methyl- N-[2-(dimethylamino)ethyl]-, dihydrochloride |
0.0490935610249072 |
0.14149162 |
NSC 685865 |
Null |
0.0490935610249072 |
-0.13926369 |
NSC 702045 |
2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(3,4-dimethoxyphenyl)- |
0.0490935610249072 |
0.56338681 |
NSC 723906 |
1,4-di-N-oxide-6,7-difluor-2-phenylcarbonyl-3-trifluormethyl quinoxaline |
0.0490935610249072 |
0.56952726 |
NSC 740252 |
Null |
0.0490935610249072 |
0.38748068 |
NSC 750970 |
3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone |
0.0490935610249072 |
-0.27903839 |
NSC 756140 |
GSK1220512A |
0.0490935610249072 |
0.063040011 |